As of September 30, 2026, Abbott Laboratories carries a market capitalization of 152.76B, placing it among publicly traded companies globally. Its enterprise value stands at 176.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 152.76B |
| Enterprise Value | 176.98B |
Abbott Laboratories's next confirmed earnings release is scheduled for January 27, 2027.
| Earnings Date | 1/27/2027 |
As of September 30, 2026, Abbott Laboratories has 1.73B shares outstanding.
| Shares Outstanding | 1.73B |
These figures are as of September 30, 2026.
| PB Ratio | 3.39 |
| P/TBV Ratio | -143.44 |
As of September 30, 2026, Abbott Laboratories maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.45 |
| Quick Ratio | 1.00 |
| Debt / Equity | 60.36 |
These figures cover the twelve months ended September 30, 2026.
| Employee Count | 115,000.00 |
Over the twelve months ended September 30, 2026, Abbott Laboratories recorded 1.12B in income tax expense.
| Income Tax | 1.12B |
As of the close on November 17, 2026, Abbott Laboratories's stock has declined approximately 13.56% over the past 52 weeks. The 50-day moving average sits at 92.22, while the 200-day moving average is 88.12.
| 52-Week Price Change | -13.56% |
| 50-Day Moving Average | 92.22 |
| 200-Day Moving Average | 88.12 |
As of September 30, 2026, Abbott Laboratories holds 3.79B in cash and equivalents against 27.49B in total debt, resulting in a net debt position of 23.92B. Total book value stands at 45.02B, with working capital of 6.48B providing operational flexibility.
| Cash & Cash Equivalents | 3.79B |
| Total Debt | 27.49B |
| Net Debt | 23.92B |
| Equity (Book Value) | 45.02B |
| Book Value Per Share | 25.99 |
| Working Capital | 6.48B |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -1.41B |
Over the twelve months ended September 30, 2026, Abbott Laboratories paid dividends of 1.64 per share.
| Dividend Per Share | 1.64 |
Abbott Laboratories's most recent stock split took place on June 1, 1998 with a 1:2 split ratio.
| Last Split Date | 6/1/1998 |
| Split Ratio | 1:2 |